908 Devices Inc. (NASDAQ:MASS) CEO Purchases $56,000.00 in Stock

908 Devices Inc. (NASDAQ:MASS) CEO Kevin J. Knopp purchased 10,000 shares of the firm’s stock in a transaction on Tuesday, May 7th. The stock was acquired at an average cost of $5.60 per share, with a total value of $56,000.00. Following the transaction, the chief executive officer now directly owns 468,981 shares in the company, valued at $2,626,293.60. The purchase was disclosed in a filing with the SEC, which is available at this link.

908 Devices Price Performance

MASS opened at $5.76 on Friday. The stock has a market capitalization of $189.96 million, a price-to-earnings ratio of -5.38 and a beta of 1.02. The business has a fifty day moving average price of $6.41 and a 200 day moving average price of $7.07. 908 Devices Inc. has a 12 month low of $4.85 and a 12 month high of $12.51.

908 Devices (NASDAQ:MASS) last released its earnings results on Tuesday, April 30th. The company reported ($0.33) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.36) by $0.03. 908 Devices had a negative net margin of 68.57% and a negative return on equity of 20.47%. The firm had revenue of $9.99 million for the quarter, compared to analyst estimates of $9.29 million. During the same period in the prior year, the firm earned ($0.39) earnings per share. The business’s quarterly revenue was up 5.3% compared to the same quarter last year. On average, research analysts anticipate that 908 Devices Inc. will post -1.11 earnings per share for the current year.

Institutional Investors Weigh In On 908 Devices

Several institutional investors have recently modified their holdings of MASS. ARK Investment Management LLC increased its holdings in 908 Devices by 8.3% in the fourth quarter. ARK Investment Management LLC now owns 4,346,579 shares of the company’s stock valued at $48,769,000 after buying an additional 333,119 shares during the last quarter. Granahan Investment Management LLC increased its holdings in shares of 908 Devices by 10.6% in the 4th quarter. Granahan Investment Management LLC now owns 2,038,658 shares of the company’s stock valued at $22,874,000 after acquiring an additional 195,368 shares during the last quarter. Iron Triangle Partners LP raised its position in shares of 908 Devices by 31.1% during the 4th quarter. Iron Triangle Partners LP now owns 1,284,947 shares of the company’s stock worth $14,417,000 after acquiring an additional 304,484 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. lifted its stake in 908 Devices by 3.0% during the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 629,994 shares of the company’s stock worth $4,196,000 after purchasing an additional 18,492 shares during the last quarter. Finally, AWM Investment Company Inc. acquired a new position in 908 Devices in the third quarter valued at approximately $3,740,000. 88.06% of the stock is owned by hedge funds and other institutional investors.

About 908 Devices

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.